MCI Launches New Radiation Technology

The USA Health Mitchell Cancer Institute (MCI) recently unveiled $2.5 million in advanced technology with the Elekta Versa HD, a medical linear accelerator that aims radiation at cancer cells while sparing the surrounding tissue. The new Versa HD and a similar machine at MCI’s Fairhope location are the only linear accelerators in South Alabama made by the Swedish company Elekta. Using the Versa HD, the radiation oncology team at MCI can create a 3D digital sculpture detailing how doses of radiation will be delivered to a patient’s tumor. During treatment, the patient lies on a robotic table that can be adjusted using six-dimensional repositioning. The Versa HD uses a surface-guided arm, can target very small tumors and adjusts based on a patient’s breathing. Such precision helps to spare surrounding tissue and reduces side effects for patients. One of the most common treatments for cancer, radiation therapy may be used by itself or with other treatments such as surgery, chemotherapy, hormone therapy and targeted therapy.

Read More

Wellhouse Real Estate Adds Two Agents In Orange Beach

Wellhouse Real Estate Adds Two Agents In Orange Beach

Baldwin County Forensics Foundation Fundraiser Announced

Baldwin County Forensics Foundation Fundraiser Announced

MBA Executive Committee To Slate 2027 Positions

MBA Executive Committee To Slate 2027 Positions

Mobile, Baldwin County Bar Associations Hosting Joint Social

Mobile, Baldwin County Bar Associations Hosting Joint Social

Warren Averett Technology Group Named A Top MSP

Warren Averett Technology Group Named A Top MSP

USA Health Surgeon Performs First-In-Area Procedure Robotically

USA Health Surgeon Performs First-In-Area Procedure Robotically

USA Health Adds Urologist Specializing In Men’s Health

USA Health Adds Urologist Specializing In Men’s Health

Foley Library Opens

Foley Library Opens

Foley Airport Updates

Foley Airport Updates

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.